A phase II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study
John K. Chan, Wei Deng, Robert V. Higgins, Krishnansu S. Tewari, Albert J. Bonebrake, Michael Hicks, Stephanie Gaillard, Pedro T. Ramirez, Weldon Chafe, Bradley J. Monk, Carol Aghajanian
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'A phase II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study'. Together they form a unique fingerprint.